Joyce is a Research Associate within the Vaccine Epidemiology Research Group (VERG) in the Department of Infectious Disease Epidemiology. Her work focuses on improving molecular detection assays and next-generation sequencing approaches for poliovirus detection in stool and environmental samples.
Previously she worked as a Senior Scientist at the Integrated COVID Hub North East and as a Project Scientist at Public Health England within the Enteric Virus Unit.
Joyce participated as an Early Stage Researcher in the EU-Funded Marie Skłodowska-Curie Action training network HONOURs (grant agreement number 721367) consisting of 10 high profile universities, research institutions and companies across Europe. As part of the HONOURs training, she completed her PhD in Biochemistry and Molecular Biology at the University of Bern, Switzerland where her work focused on the identification and characterisation of emerging viruses from clinical and environmental samples i.e. human adenoviruses isolated from patients in Bern, Switzerland, over a 20 year period, and arboviruses (TBEV, DENV, CHIKV and ZIKV) of public health concern found in ticks and mosquitoes. She also obtained an MSc in Molecular Biology of Infectious Diseases from the London School of Hygiene and Tropical Medicine and a BSc in Biomedical Sciences.
et al., 2020, Preparedness needs research: How fundamental science and international collaboration accelerated the response to COVID-19., Plos Pathogens, Vol:16, ISSN:1553-7366, Pages:1-12
et al., 2020, Evaluation of viral RNA recovery methods in vectors by metagenomic sequencing., Viruses, Vol:12, ISSN:1999-4915, Pages:1-17
et al., 2020, Epidemiology of human adenoviruses: a 20-year retrospective observational study in hospitalized patients in Bern, Switzerland., Clin Epidemiol, Vol:12, ISSN:1179-1349, Pages:353-366
et al., 2018, Isolation of vaccine-like poliovirus strains in sewage samples from the United Kingdom., Journal of Infectious Diseases, Vol:217, ISSN:0022-1899, Pages:1222-1230
et al., Genomic analyses of human adenoviruses unravel novel recombinant genotypes associated with severe infections in pediatric patients